ArticleBMC rheumatology2024

Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study.

Akira Maeyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.